• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 Microsoft Kinect 传感器测量精神病青少年的运动:一项探索评估抗精神病药引起的帕金森病的新工具的初步研究。

Measuring movements in adolescents with psychosis using the Microsoft Kinect sensor: a pilot study exploring a new tool for assessing aspects of antipsychotic-induced parkinsonism.

机构信息

Centre for Child and Adolescent Mental Health, Mental Health Services, Capital Region of Denmark, Glostrup, Denmark.

Faculty of Health Science, University of Copenhagen, Copenhagen, Denmark.

出版信息

Child Adolesc Ment Health. 2020 May;25(2):79-94. doi: 10.1111/camh.12360. Epub 2020 Jan 7.

DOI:10.1111/camh.12360
PMID:32307841
Abstract

BACKGROUND

The assessment of motor disturbances in antipsychotic-treated adolescent patients is often limited to the use of observer-based rating scales with interobserver variability. The objectives of this pilot study were to measure movement patterns associated with antipsychotic-induced parkinsonism in young patients with psychosis and initiating/treated with antipsychotics, using a computer application connected with the Microsoft Kinect sensor (Motorgame).

METHOD

All participants were assessed by neurological examination, clinical side effect rating scales (Udvalg for Kliniske Undersøgelser Side Effect Rating Scale, Barnes Akathisia Rating Scale, Simpson Angus Scale (SAS), and Abnormal Involuntary Movement Scale), and the Motorgame. Furthermore, speed of information processing and motor speed with subtests from the Brief Assessment of Cognition in Schizophrenia test battery was assessed.

RESULTS

We included 21 adolescents with first-episode psychosis (62% treated with antipsychotics; males 38%; mean age 16 ± 1.4 years) and 69 healthy controls (males 36%; mean age 16 ± 1.5 years). Prolonged time of motor performance (TOMP) in the Motorgame was associated with higher SAS scores for arm dropping (p = .009). A consistent practice effect was detected (p < .001). We found no significant associations between TOMP and age, height, body weight, sex, antipsychotic dosage, or information processing speed.

CONCLUSIONS

We found an uncorrected significant association between prolonged TOMP and shoulder bradykinesia. The Motorgame was found useful in assessing parkinsonian symptoms in early-onset psychosis and accepted by participants. Future studies of larger cohorts, including patients with high scores in clinical motor side effect scales, are required to establish solid validity of the novel test.

摘要

背景

评估抗精神病药物治疗的青少年患者的运动障碍通常仅限于使用观察者为基础的评定量表,其存在观察者间变异性。本研究的目的是使用与 Microsoft Kinect 传感器(Motorgame)相连的计算机应用程序来测量与抗精神病药物引起的帕金森病相关的运动模式,该程序应用于年轻的精神病患者,这些患者正在接受或刚接受抗精神病药物治疗。

方法

所有参与者均接受神经系统检查、临床副作用评定量表(Udvalg for Kliniske Undersøgelser Side Effect Rating Scale、Barnes 静坐不能评定量表、Simpson Angus 量表和不自主运动量表)和 Motorgame 评估。此外,还评估了信息处理速度和Brief Assessment of Cognition in Schizophrenia 测试组合中的运动速度的子测试。

结果

我们纳入了 21 名首发精神病的青少年(62%接受抗精神病药物治疗;男性占 38%;平均年龄 16±1.4 岁)和 69 名健康对照者(男性占 36%;平均年龄 16±1.5 岁)。Motorgame 中的运动表现延长时间(TOMP)与 SAS 中手臂下垂评分较高(p=0.009)相关。发现了一致的练习效应(p<0.001)。我们没有发现 TOMP 与年龄、身高、体重、性别、抗精神病药物剂量或信息处理速度之间存在显著相关性。

结论

我们发现未经校正的 TOMP 与肩部运动迟缓之间存在显著关联。Motorgame 可用于评估早期精神病患者的帕金森症状,并得到参与者的认可。需要进行更大队列的未来研究,包括临床运动副作用量表评分较高的患者,以确定该新测试的有效性。

相似文献

1
Measuring movements in adolescents with psychosis using the Microsoft Kinect sensor: a pilot study exploring a new tool for assessing aspects of antipsychotic-induced parkinsonism.使用 Microsoft Kinect 传感器测量精神病青少年的运动:一项探索评估抗精神病药引起的帕金森病的新工具的初步研究。
Child Adolesc Ment Health. 2020 May;25(2):79-94. doi: 10.1111/camh.12360. Epub 2020 Jan 7.
2
Exploring Movement Impairments in Patients With Parkinson's Disease Using the Microsoft Kinect Sensor: A Feasibility Study.使用微软Kinect传感器探索帕金森病患者的运动障碍:一项可行性研究。
Front Neurol. 2021 Jan 6;11:610614. doi: 10.3389/fneur.2020.610614. eCollection 2020.
3
Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.抗精神病药物与心理干预及两者联合用于首发精神病青少年(MAPS):一项多中心、三臂、随机对照试验性及可行性研究
Lancet Psychiatry. 2020 Sep;7(9):788-800. doi: 10.1016/S2215-0366(20)30248-0. Epub 2020 Jul 7.
4
Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders.甲基苯丙胺使用与精神病患者抗精神病药相关的锥体外系副作用。
J Dual Diagn. 2020 Apr-Jun;16(2):208-217. doi: 10.1080/15504263.2020.1714099. Epub 2020 Jan 26.
5
Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.儿童和青少年首发精神病的抗精神病药物治疗:纵向自然主义方法
J Child Adolesc Psychopharmacol. 2008 Aug;18(4):327-36. doi: 10.1089/cap.2007.0138.
6
Quality of life and functioning in first-episode psychosis Chinese patients with different antipsychotic medications.首发精神病患者采用不同抗精神病药物治疗的生活质量和功能状况。
Early Interv Psychiatry. 2016 Dec;10(6):535-539. doi: 10.1111/eip.12246. Epub 2015 May 12.
7
[Minor neurological and physical anomalies in patients with first-episode psychosis].[首发精神病患者的轻微神经和身体异常]
Encephale. 2013 Jun;39(3):149-54. doi: 10.1016/j.encep.2012.06.030. Epub 2012 Oct 12.
8
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.评估老年精神分裂症的抗精神病药剂量减少:一项前瞻性多巴胺 D2/3 受体占有率研究。
JAMA Psychiatry. 2015 Sep;72(9):927-34. doi: 10.1001/jamapsychiatry.2015.0891.
9
Effectiveness, safety, and tolerability of risperidone in adolescents with schizophrenia: an open-label study.利培酮治疗青少年精神分裂症的有效性、安全性及耐受性:一项开放标签研究。
J Child Adolesc Psychopharmacol. 2003 Fall;13(3):319-27. doi: 10.1089/104454603322572651.
10
Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study.莫达非尼改善抗精神病药引起的帕金森病,但不能改善精神分裂症和分裂情感障碍患者的白天过度嗜睡、精神症状或认知:一项随机、双盲、安慰剂对照研究。
Schizophr Res. 2013 Oct;150(1):289-96. doi: 10.1016/j.schres.2013.07.039. Epub 2013 Aug 9.